CFO Richard Pulik sells $12.5M of Roivant Sciences Ltd. stock
An open-market sale between Nov 10 and Nov 11, reported to the SEC on Nov 12, not marked as part of a 10b5-1 plan.
Richard Pulik, a chief financial officer of Roivant Sciences Ltd. (ROIV), sold 300,000 shares between Nov 10 and Nov 11 at an average price of $41.58, a total of about $12 million, according to a Form 4 filed with the SEC on Nov 12.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 222,046 shares held. It is the 13th insider sale at Roivant Sciences Ltd. reported in the last 90 days.
Details from the SEC filing:
| Company | Roivant Sciences Ltd. (ROIV) |
|---|---|
| Insider | Richard Pulik |
| Role | CFO |
| Transaction | Open-market sale (code S) |
| Shares | 300,000 |
| Average price | $41.58 |
| Value | $12,473,272 |
| Trade dates | Nov 10 to Nov 11, 2026 |
| Filed with the SEC | Nov 12, 2026, 7:01 PM ET |
| Shares held after | 222,046 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
See the latest cluster buys and sells · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.